Investigation of neuronal autoantibodies in two different focal epilepsy syndromes

Epilepsia

Volumn 55, Issue 3, 2014, Pages 414-422

  Ekizoglu, Esme ^a   Tuzun, Erdem ^b   Woodhall, Mark ^c   Lang, Bethan ^c   Jacobson, Leslie ^c   Icoz, Sema ^a   Bebek, Nerses ^a   Gurses, Candan ^a   Gokyigit, Aysen ^a   Waters, Patrick ^c   Vincent, Angela ^c   Baykan, Betul ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Autoantibodies; Epilepsy; Glycine receptor; N methyl d aspartate receptor; Voltage gated potassium channel

Indexed keywords

ANTICONVULSIVE AGENT; AUTOANTIBODY; CARBAMAZEPINE; CONTACTIN ASSOCIATED PROTEIN 2; CYCLOPHOSPHAMIDE; ETIRACETAM; GLYCINE RECEPTOR; GLYCOPROTEIN; IMMUNOGLOBULIN; METHYLPREDNISOLONE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PREDNISOLONE; PREGABALIN; RITUXIMAB; TOPIRAMATE; UNCLASSIFIED DRUG; VALPROIC ACID; VOLTAGE GATED POTASSIUM CHANNEL; ZONISAMIDE;

ADULT; ANTIBODY TITER; COMORBIDITY; CONFERENCE PAPER; CONTROLLED STUDY; ELECTROENCEPHALOGRAPHY; FEMALE; FOCAL EPILEPSY; HIPPOCAMPAL SCLEROSIS; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; MESIAL TEMPORAL LOBE EPILEPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STEROID THERAPY; TREATMENT RESPONSE; VAGUS NERVE STIMULATION; WHITE MATTER;

AUTOANTIBODIES; EPILEPSY; GLYCINE RECEPTOR; N-METHYL-D-ASPARTATE RECEPTOR; VOLTAGE-GATED POTASSIUM CHANNEL;

ADULT; AUTOANTIBODIES; EPILEPSIES, PARTIAL; FEMALE; HEK293 CELLS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NERVE FIBERS, MYELINATED; NEURONS; SYNDROME; YOUNG ADULT;

EID: 84896331160     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.12528     Document Type: Conference Paper

References (39)

1. Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 2010; 51: 676-685.
2. Brodie MJ, Barry SJ, Bamagous GA, et al. Patterns of treatment response in newly diagnosed epilepsy. Neurology 2012; 78: 1548-1554.
3. Brenner T, Sills GJ, Hart Y, et al. Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy. Epilepsia 2013; 54: 1028-1035.
4. Majoie HJ, de Baets M, Renier W, et al. Antibodies to voltage-gated potassium and calcium channels in epilepsy. Epilepsy Res 2006; 71: 135-141.
5. McKnight K, Jiang Y, Hart Y, et al. Serum antibodies in epilepsy and seizure-associated disorders. Neurology 2005; 65: 1730-1736.
6. Irani SR, Bera K, Waters P, et al. N-methyl- d -aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 2010; 133: 1655-1667.
7. Liimatainen S, Peltola M, Sabater L, et al. Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsy. Epilepsia 2010; 51: 760-767.
8. Quek AM, Britton JW, McKeon A, et al. Autoimmune epilepsy: clinical characteristics and response to immunotherapy. Arch Neurol 2012; 69: 582-593.
9. Yang T, Zhou D, Stefan H,. Why mesial temporal lobe epilepsy with hippocampal sclerosis is progressive: uncontrolled inflammation drives disease progression? J Neurol Sci 2010; 296: 1-6.
10. Blume WT, Luders HO, Mizrahi E, et al. Glossary of descriptive terminology for ictal semiology: report of the ILAE task force on classification and terminology. Epilepsia 2001; 42: 1212-1218.
11. Irani SR, Alexander S, Waters P, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis. Morvan's syndrome and acquired neuromyotonia. Brain 2010; 133: 2734-2748.
12. Motomura M, Johnston I, Lang B, et al. An improved diagnostic assay for Lambert-Eaton myasthenic syndrome. J Neurol Neurosurg Psychiatry 1995; 58: 85-87.
13. Vincent A, Grimaldi LM, Martino G, et al. Antibodies to 125I-glutamic acid decarboxylase in patients with stiff man syndrome. J Neurol Neurosurg Psychiatry 1997; 62: 395-397.
14. Irani SR, Bien CG, Lang B,. Autoimmune epilepsies. Curr Opin Neurol 2011; 24: 146-153.
15. Hutchinson M, Waters P, McHugh J, et al. Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody. Neurology 2008; 71: 1291-1292.
16. Clerinx K, Breban T, Schrooten M, et al. Progressive encephalomyelitis with rigidity and myoclonus: resolution after thymectomy. Neurology 2011; 76: 303-304.
17. Schmitt SE, Pargeon K, Frechette ES, et al. Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis. Neurology 2012; 79: 1094-1100.
18. Vincent A, Buckley C, Schott JM, et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 2004; 127: 701-712.
19. Graus F, Saiz A, Lai M, et al. Neuronal surface antigen antibodies in limbic encephalitis: clinical-immunologic associations. Neurology 2008; 71: 930-936.
20. Haberlandt E, Bast T, Ebner A, et al. Limbic encephalitis in children and adolescents. Arch Dis Child 2001; 96: 186-191.
21. Bien CG, Elger CE,. Limbic encephalitis: a cause of temporal lobe epilepsy with onset in adult life. Epilepsy Behav 2007; 10: 529-538.
22. Kroll-Seger J, Bien CG, Huppertz HJ,. Non-paraneoplastic limbic encephalitis associated with antibodies to potassium channels leading to bilateral hippocampal sclerosis in a pre-pubertal girl. Epileptic Disord 2009; 11: 54-59.
23. Suleiman J, Brenner T, Gill D, et al. VGKC antibodies in pediatric encephalitis presenting with status epilepticus. Neurology 2011; 76: 1252-1255.
24. Aykutlu E, Baykan B, Gurses C, et al. No association of anti-GM1 and anti-GAD antibodies with juvenile myoclonic epilepsy: a pilot study. Seizure 2005; 14: 362-366.
25. Errichiello L, Perruolo G, Pascarella A, et al. Autoantibodies to glutamic acid decarboxylase (GAD) in focal and generalized epilepsy: a study on 233 patients. J Neuroimmunol 2009; 211: 120-123.
26. Saiz A, Blanco Y, Sabater L, et al. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain 2008; 131: 2553-2563.
27. Cikrikçili U, Ulusoy C, Turan S, et al. Non-convulsive status epilepticus associated with glutamic acid decarboxylase antibody. Clin EEG Neurosci 2013; 44: 232-236.
28. Lai M, Hughes EG, Peng X, et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol 2009; 65: 424-434.
29. Adelow C, Andersson T, Ahlbom A, et al. Unprovoked seizures in multiple sclerosis and systemic lupus erythematosus: a population-based case-control study. Epilepsy Res 2012; 101: 284-287.
30. Appenzeller S, Cendes F, Costallat LT,. Epileptic seizures in systemic lupus erythematosus. Neurology 2004; 63: 1808-1812.
31. Vincent A, Crino PB,. Systemic and neurologic autoimmune disorders associated with seizures or epilepsy. Epilepsia 2011; 52 (Suppl. 3): 12-17.
32. Zuliani L, Graus F, Giometto B, et al. Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognition. J Neurol Neurosurg Psychiatry 2012; 83: 638-645.
33. Niehusmann P, Dalmau J, Rudlowski C, et al. Diagnostic value of N-methyl- d -aspartate receptor antibodies in women with new-onset epilepsy. Arch Neurol 2009; 66: 458-464.
34. Dinia L, Bonzano L, Albano B, et al. White matter lesions progression in migraine with aura: a clinical and MRI longitudinal study. J Neuroimaging 2013; 23: 47-52.
35. Barry H, Hardiman O, Healy DG, et al. Anti-NMDA receptor encephalitis: an important differential diagnosis in psychosis. Br J Psychiatry 2011; 199: 508-509.
36. Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008; 7: 1091-1098.
37. Lennox BR, Coles AJ, Vincent A,. Antibody-mediated encephalitis: a treatable cause of schizophrenia. Br J Psychiatry 2012; 200: 92-94.
38. Parthasarathi UD, Harrower T, Tempest M, et al. Psychiatric presentation of voltage-gated potassium channel antibody-associated encephalopathy. Case report. Br J Psychiatry 2006; 189: 182-183.
39. Zandi MS, Irani SR, Lang B, et al. Disease-relevant autoantibodies in first episode schizophrenia. J Neurol 2011; 258: 686-688.